Stocks›Healthcare›PGNY

PGNY Progyny, Inc.

NasdaqResearch view

Progyny, Inc. operates in the Services-Misc Health & Allied Services, Nec industry.

$26.86−2.17%
Oct 16 close · 1D EOD · Databento
HealthcareServices-Misc Health & Allied Services, NecMid-capSEC EDGAR FY 2025-12-31

On the WireNo stories on PGNY yet. Follow the company and the next one lands in Following.

The numbers · FY2025, filed

SEC EDGAR
Market cap$2.1B
Revenue$1.3B+10.40%
Net income$58.5M
EPS, diluted$0.65+14.00%
Gross margin23.6%
Operating margin6.6%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$2.1B
Enterprise Value$1.9B
Income$58.5M
Sales$1.3B
Book/sh$6.73
Cash/sh$1.49
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio—
Current Ratio2.73
Debt/Eq—
EPS (ttm)$0.65
EPS this Y14.0%
EPS past 3/5Y29.4%
Sales past 3/5Y17.9%
EPS Y/Y TTM14.0%
Sales Y/Y TTM10.4%
Shs Outstand76.73M
ROA7.9%
ROE11.3%
ROIC13.0%
Gross Margin23.6%
Oper. Margin6.6%
Profit Margin4.5%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$500.6M
FY21
$786.9M
FY22
$1.1B
FY23
$1.2B
FY24
$1.3B
FY25

Operating leverage — margins

GrossOperatingNet
0%40%80%24%7%5%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.